
LINK . SPRINGER . COM {
}
Title:
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy | Arthritis Research & Therapy
Description:
Objectives Adult-onset Still’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more prominent role in the treatment, their place requires clarification. This study aimed to identify factors predictive of treatment response to anakinra or tocilizumab and investigate whether the choice of biotherapy and delays in the initiation of biotherapy influenced the likelihood of steroid discontinuation. Methods A multicenter exploratory retrospective study included all patients diagnosed with AOSD and receiving biological treatments in three regional hospitals until 2018. Clinical and biological characteristics at diagnosis and treatment-related data were collected. The nonparametric Mann-Whitney test was used to perform univariate analysis for quantitative variables, and Fisher’s exact test was used for qualitative variables. Results Twenty-seven patients were included. All but one patient achieved remission with either anakinra or tocilizumab. Treatment responses depended on disease phenotype: the presence of arthritis and a chronic articular phenotype were associated with a substantial response to tocilizumab with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively, whereas the systemic form and the absence of arthritis were associated with a substantial response to anakinra with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively. Tocilizumab increased the likelihood of corticosteroid withdrawal (p = 0.029) regardless of delays in initiation or when it was initiated relative to other treatment in the overall therapeutic strategy. Conclusion This study highlights the therapeutic implications of the phenotypic dichotomy of AOSD and should help us better codify AOSD treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Health & Fitness
- Science
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We see no obvious way the site makes money.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.
Keywords {🔍}
disease, patients, tocilizumab, anakinra, treatment, aosd, stills, study, article, adultonset, google, scholar, pubmed, arthritis, form, systemic, chronic, articular, biological, cas, months, response, data, phenotype, clinical, received, corticosteroids, efficacy, withdrawal, refractory, biotherapy, responded, rheumatol, diagnosis, iqr, results, presented, median, adult, likelihood, delay, clin, analysis, initiation, table, stop, fautrel, corticosteroid, therapeutic, phenotypes,
Topics {✒️}
gov/pmc/articles/pmc3390042/ saiki gov/pmc/articles/pmc4616841/ giampietro multiple drug-resistant adult-onset marie-elise truchetet gov/pmc/articles/pmc3437651/ anti-cd20 monoclonal antibody anti-extractable nuclear antigen traditional therapy-resistant adult-onset serra lópez-matencio jm increased c-reactive protein conventional treatment-refractory adult-onset nonparametric mann-whitney test thierry schaeverbeke anti-dna positive article download pdf tumor necrosis factor secure evidence-based medicine targeted therapies macrophage activation syndrome strong steroid-sparing effect clear steroid-sparing effect potential life-threatening complications ear-nose-throat il recent meta-analysis showing label anti-interleukin-1 treatments il-1r inhibitor anakinra service de rhumatologie future large-scale studies nonsteroidal anti-inflammatories reactive hemophagocytic lymphohistiocytosis randomized controlled trial privacy choices/manage cookies treating refractory adult-onset infectious-induced aosd flare anakinra-treated patients group tocilizumab-treated patients group ear-nose-throat gerfaud-valentin creative commons license recent meta-analysis suggested gonzález-gay ma clinical aosd-related characteristics anti-tnf blockers evidence-based review life-threatening conditions arthritis res ther steroid-refractory flares bordeaux teaching hospital bordeaux university hospital long-term therapy
Questions {❓}
- How might this impact clinical practice?
- Therapeutic innovation in adult-onset Still’s disease (and other rare inflammatory disorders): how to secure evidence-based medicine?
- What are the new lines of research suggested by this study?
- What is already known about this subject?
Schema {🗺️}
WebPage:
mainEntity:
headline:Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
description:Adult-onset Still’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more prominent role in the treatment, their place requires clarification. This study aimed to identify factors predictive of treatment response to anakinra or tocilizumab and investigate whether the choice of biotherapy and delays in the initiation of biotherapy influenced the likelihood of steroid discontinuation. A multicenter exploratory retrospective study included all patients diagnosed with AOSD and receiving biological treatments in three regional hospitals until 2018. Clinical and biological characteristics at diagnosis and treatment-related data were collected. The nonparametric Mann-Whitney test was used to perform univariate analysis for quantitative variables, and Fisher’s exact test was used for qualitative variables. Twenty-seven patients were included. All but one patient achieved remission with either anakinra or tocilizumab. Treatment responses depended on disease phenotype: the presence of arthritis and a chronic articular phenotype were associated with a substantial response to tocilizumab with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively, whereas the systemic form and the absence of arthritis were associated with a substantial response to anakinra with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively. Tocilizumab increased the likelihood of corticosteroid withdrawal (p = 0.029) regardless of delays in initiation or when it was initiated relative to other treatment in the overall therapeutic strategy. This study highlights the therapeutic implications of the phenotypic dichotomy of AOSD and should help us better codify AOSD treatment.
datePublished:2019-02-12T00:00:00Z
dateModified:2019-02-12T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13075-019-1838-6
keywords:
Adult-onset Still’s disease
Tocilizumab
Anakinra
Treatment strategy
Biologics
Rheumatology
Orthopedics
image:
isPartOf:
name:Arthritis Research & Therapy
issn:
1478-6362
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:François Vercruysse
url:http://orcid.org/0000-0002-0874-0308
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Thomas Barnetche
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Estibaliz Lazaro
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
address:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
type:PostalAddress
type:Organization
type:Person
name:Emilie Shipley
affiliation:
name:Centre Hospitalier de Dax, Service de Rhumatologie
address:
name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
type:PostalAddress
type:Organization
type:Person
name:François Lifermann
affiliation:
name:Centre Hospitalier de Dax, Service de Médecine Interne
address:
name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
type:PostalAddress
type:Organization
type:Person
name:Alexandre Balageas
affiliation:
name:Centre Hospitalier de Pau, Service de Rhumatologie
address:
name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
type:PostalAddress
type:Organization
type:Person
name:Xavier Delbrel
affiliation:
name:Centre Hospitalier de Pau, Service de Médecine Interne
address:
name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
type:PostalAddress
type:Organization
type:Person
name:Bruno Fautrel
affiliation:
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
address:
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
type:PostalAddress
type:Organization
type:Person
name:Christophe Richez
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Thierry Schaeverbeke
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Marie-Elise Truchetet
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
description:Adult-onset Still’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more prominent role in the treatment, their place requires clarification. This study aimed to identify factors predictive of treatment response to anakinra or tocilizumab and investigate whether the choice of biotherapy and delays in the initiation of biotherapy influenced the likelihood of steroid discontinuation. A multicenter exploratory retrospective study included all patients diagnosed with AOSD and receiving biological treatments in three regional hospitals until 2018. Clinical and biological characteristics at diagnosis and treatment-related data were collected. The nonparametric Mann-Whitney test was used to perform univariate analysis for quantitative variables, and Fisher’s exact test was used for qualitative variables. Twenty-seven patients were included. All but one patient achieved remission with either anakinra or tocilizumab. Treatment responses depended on disease phenotype: the presence of arthritis and a chronic articular phenotype were associated with a substantial response to tocilizumab with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively, whereas the systemic form and the absence of arthritis were associated with a substantial response to anakinra with p = 0.0009 (OR 36 [2.6–1703]) and p = 0.017 (OR 10 [1.22–92.6]), respectively. Tocilizumab increased the likelihood of corticosteroid withdrawal (p = 0.029) regardless of delays in initiation or when it was initiated relative to other treatment in the overall therapeutic strategy. This study highlights the therapeutic implications of the phenotypic dichotomy of AOSD and should help us better codify AOSD treatment.
datePublished:2019-02-12T00:00:00Z
dateModified:2019-02-12T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13075-019-1838-6
keywords:
Adult-onset Still’s disease
Tocilizumab
Anakinra
Treatment strategy
Biologics
Rheumatology
Orthopedics
image:
isPartOf:
name:Arthritis Research & Therapy
issn:
1478-6362
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:François Vercruysse
url:http://orcid.org/0000-0002-0874-0308
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Thomas Barnetche
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Estibaliz Lazaro
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
address:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
type:PostalAddress
type:Organization
type:Person
name:Emilie Shipley
affiliation:
name:Centre Hospitalier de Dax, Service de Rhumatologie
address:
name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
type:PostalAddress
type:Organization
type:Person
name:François Lifermann
affiliation:
name:Centre Hospitalier de Dax, Service de Médecine Interne
address:
name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
type:PostalAddress
type:Organization
type:Person
name:Alexandre Balageas
affiliation:
name:Centre Hospitalier de Pau, Service de Rhumatologie
address:
name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
type:PostalAddress
type:Organization
type:Person
name:Xavier Delbrel
affiliation:
name:Centre Hospitalier de Pau, Service de Médecine Interne
address:
name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
type:PostalAddress
type:Organization
type:Person
name:Bruno Fautrel
affiliation:
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
address:
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
type:PostalAddress
type:Organization
type:Person
name:Christophe Richez
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Thierry Schaeverbeke
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Marie-Elise Truchetet
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Arthritis Research & Therapy
issn:
1478-6362
volumeNumber:21
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
address:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
type:PostalAddress
name:Centre Hospitalier de Dax, Service de Rhumatologie
address:
name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
type:PostalAddress
name:Centre Hospitalier de Dax, Service de Médecine Interne
address:
name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
type:PostalAddress
name:Centre Hospitalier de Pau, Service de Rhumatologie
address:
name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
type:PostalAddress
name:Centre Hospitalier de Pau, Service de Médecine Interne
address:
name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
type:PostalAddress
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
address:
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
type:PostalAddress
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:François Vercruysse
url:http://orcid.org/0000-0002-0874-0308
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
email:[email protected]
name:Thomas Barnetche
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
name:Estibaliz Lazaro
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne
address:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
type:PostalAddress
type:Organization
name:Emilie Shipley
affiliation:
name:Centre Hospitalier de Dax, Service de Rhumatologie
address:
name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
type:PostalAddress
type:Organization
name:François Lifermann
affiliation:
name:Centre Hospitalier de Dax, Service de Médecine Interne
address:
name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
type:PostalAddress
type:Organization
name:Alexandre Balageas
affiliation:
name:Centre Hospitalier de Pau, Service de Rhumatologie
address:
name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
type:PostalAddress
type:Organization
name:Xavier Delbrel
affiliation:
name:Centre Hospitalier de Pau, Service de Médecine Interne
address:
name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
type:PostalAddress
type:Organization
name:Bruno Fautrel
affiliation:
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie
address:
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
type:PostalAddress
type:Organization
name:Christophe Richez
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
name:Thierry Schaeverbeke
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
name:Marie-Elise Truchetet
affiliation:
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie
address:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
type:PostalAddress
type:Organization
PostalAddress:
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
name:Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Médecine Interne, Pessac, France
name:Centre Hospitalier de Dax, Service de Rhumatologie, Dax, France
name:Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France
name:Centre Hospitalier de Pau, Service de Rhumatologie, Pau, France
name:Centre Hospitalier de Pau, Service de Médecine Interne, Pau, France
name:Centre Hospitalier Universitaire de Paris, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
name:Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Service de Rhumatologie, Bordeaux, France
External Links {🔗}(169)
- https://www.springernature.com/gp/authors's total income per month
- How much cash flow does https://link.springernature.com/home/ have monthly?
- How much does https://order.springer.com/public/cart make?
- How much income does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research have?
- What's https://arthritis-research.biomedcentral.com/about's gross income?
- Get to know https://submission.nature.com/new-submission/13075/3's earnings
- Profit of https://orcid.org/0000-0002-0874-0308
- Find out how much https://doi.org/10.1136%2Fard.54.7.587 earns monthly
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7668903
- What is the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1009940?
- See how much http://scholar.google.com/scholar_lookup?&title=Epidemiology%20of%20adult%20Still%E2%80%99s%20disease%3A%20estimate%20of%20the%20incidence%20by%20a%20retrospective%20study%20in%20West%20France&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.54.7.587&volume=54&issue=7&pages=587-590&publication_year=1995&author=Magadur-Joly%2CG&author=Billaud%2CE&author=Barrier%2CJH&author=Pennec%2CYL&author=Masson%2CC&author=Renou%2CP makes per month
- What's the financial outcome of https://doi.org/10.1016%2Fj.berh.2016.08.003?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27886796?
- http://scholar.google.com/scholar_lookup?&title=Adult-onset%20Still%E2%80%99s%20disease%3A%20advances%20in%20the%20treatment&journal=Best%20Pract%20Res%20Clin%20Rheumatol&doi=10.1016%2Fj.berh.2016.08.003&volume=30&issue=2&pages=222-238&publication_year=2016&author=Casta%C3%B1eda%2CS&author=Blanco%2CR&author=Gonz%C3%A1lez-Gay%2CMA's revenue stream
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25388963?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Pathogenesis%20of%20adult-onset%20Still%E2%80%99s%20disease%3A%20new%20insights%20from%20the%20juvenile%20counterpart&journal=Immunol%20Res&doi=10.1007%2Fs12026-014-8561-9&volume=61&issue=1%E2%80%932&pages=53-62&publication_year=2015&author=Jamilloux%2CY&author=Gerfaud-Valentin%2CM&author=Martinon%2CF&author=Belot%2CA&author=Henry%2CT&author=S%C3%A8ve%2CP is on a monthly basis
- How much does https://doi.org/10.1016%2Fj.autrev.2014.08.032 pull in monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25183244's revenue stream
- Find out how much http://scholar.google.com/scholar_lookup?&title=Adult%20onset%20Still%E2%80%99s%20disease%20%28AOSD%29%20in%20the%20era%20of%20biologic%20therapies%3A%20dichotomous%20view%20for%20cytokine%20and%20clinical%20expressions&journal=Autoimmun%20Rev&doi=10.1016%2Fj.autrev.2014.08.032&volume=13&issue=11&pages=1149-1159&publication_year=2014&author=Maria%2CATJ&author=Quellec%2CA&author=Jorgensen%2CC&author=Touitou%2CI&author=Rivi%C3%A8re%2CS&author=Guilpain%2CP earns monthly
- Earnings of https://doi.org/10.1016%2Fj.autrev.2014.01.058
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24657513
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Adult-onset%20Still%E2%80%99s%20disease&journal=Autoimmun%20Rev&doi=10.1016%2Fj.autrev.2014.01.058&volume=13&issue=7&pages=708-722&publication_year=2014&author=Gerfaud-Valentin%2CM&author=Jamilloux%2CY&author=Iwaz%2CJ&author=S%C3%A8ve%2CP?
- How much revenue does https://doi.org/10.1093%2Frheumatology%2F40.12.1398 bring in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11752512 net monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Cytokine%20and%20immunogenetic%20profiles%20in%20Japanese%20patients%20with%20adult%20Still%E2%80%99s%20disease.%20Association%20with%20chronic%20articular%20disease&journal=Rheumatology&doi=10.1093%2Frheumatology%2F40.12.1398&volume=40&issue=12&pages=1398-1404&publication_year=2001&author=Fujii%2CT&author=Nojima%2CT&author=Yasuoka%2CH&author=Satoh%2CS&author=Nakamura%2CK&author=Kuwana%2CM make?
- Monthly income for https://doi.org/10.1016%2Fj.cyto.2012.11.025
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23276493?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Distinct%20subsets%20of%20patients%20with%20systemic%20juvenile%20idiopathic%20arthritis%20based%20on%20their%20cytokine%20profiles&journal=Cytokine&doi=10.1016%2Fj.cyto.2012.11.025&volume=61&issue=2&pages=345-348&publication_year=2013&author=Shimizu%2CM&author=Nakagishi%2CY&author=Yachie%2CA?
- How much income is https://doi.org/10.1093%2Frheumatology%2Fkeq133 earning monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20472718
- How much does http://scholar.google.com/scholar_lookup?&title=Distinct%20cytokine%20profiles%20of%20systemic-onset%20juvenile%20idiopathic%20arthritis-associated%20macrophage%20activation%20syndrome%20with%20particular%20emphasis%20on%20the%20role%20of%20interleukin-18%20in%20its%20pathogenesis&journal=Rheumatology&doi=10.1093%2Frheumatology%2Fkeq133&volume=49&issue=9&pages=1645-1653&publication_year=2010&author=Shimizu%2CM&author=Yokoyama%2CT&author=Yamada%2CK&author=Kaneda%2CH&author=Wada%2CH&author=Wada%2CT net monthly?
- How much profit does https://doi.org/10.1002%2Facr.22194 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Clinical%20manifestations%20of%20adult-onset%20Still%E2%80%99s%20disease%20presenting%20with%20erosive%20arthritis%3A%20association%20with%20low%20levels%20of%20ferritin%20and%20interleukin-18&journal=Arthritis%20Care%20Res&doi=10.1002%2Facr.22194&volume=66&issue=4&pages=642-646&publication_year=2014&author=Ichida%2CH&author=Kawaguchi%2CY&author=Sugiura%2CT&author=Takagi%2CK&author=Katsumata%2CY&author=Gono%2CT generate?
- What's the profit of https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390042/?
- What are the earnings of https://doi.org/10.1016%2Fj.clim.2004.03.023?
- See how much http://scholar.google.com/scholar_lookup?&title=Adult%20Still%E2%80%99s%20disease%20reflects%20a%20Th2%20rather%20than%20a%20Th1%20cytokine%20profile&journal=Clin%20Immunol%20Orlando%20Fla&doi=10.1016%2Fj.clim.2004.03.023&volume=112&issue=1&pages=120-125&publication_year=2004&author=Saiki%2CO&author=Uda%2CH&author=Nishimoto%2CN&author=Miwa%2CT&author=Mima%2CT&author=Ogawara%2CT makes per month
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437651?
- Get to know what's the income of https://doi.org/10.2147%2FTCRM.S155488
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29416343 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790106 bring in each month?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Biological%20therapy%20of%20traditional%20therapy-resistant%20adult-onset%20Still%E2%80%99s%20disease%3A%20an%20evidence-based%20review&journal=Ther%20Clin%20Risk%20Manag&doi=10.2147%2FTCRM.S155488&volume=14&pages=167-171&publication_year=2018&author=Zhou%2CS&author=Qiao%2CJ&author=Bai%2CJ&author=Wu%2CY&author=Fang%2CH?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23108887
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Tocilizumab%20in%20the%20treatment%20of%20the%20adult-onset%20Still%E2%80%99s%20disease%3A%20current%20clinical%20evidence&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-012-2105-2&volume=32&issue=1&pages=141-147&publication_year=2013&author=Boysson%2CH&author=F%C3%A9vrier%2CJ&author=Nicolle%2CA&author=Auzary%2CC&author=Geffray%2CL each month?
- How much does https://doi.org/10.2169%2Finternalmedicine.50.4771 earn?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21841340
- http://scholar.google.com/scholar_lookup?&title=Tocilizumab%20improved%20both%20clinical%20and%20laboratory%20manifestations%20except%20for%20Interleukin-18%20in%20a%20case%20of%20multiple%20drug-resistant%20adult-onset%20Still%E2%80%99s%20disease&journal=Intern%20Med&doi=10.2169%2Finternalmedicine.50.4771&volume=50&issue=16&pages=1757-1760&publication_year=2011&author=Yoshida%2CY&author=Sakamoto%2CM&author=Yokota%2CK&author=Sato%2CK&author=Mimura%2CT's financial summary
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20842515?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Case%20report%3A%20successful%20use%20of%20short-term%20add-on%20tocilizumab%20for%20multirefractory%20systemic%20flare%20of%20adult-onset%20Still%E2%80%99s%20disease&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-010-1562-8&volume=32&issue=Suppl%201&pages=S103-S106&publication_year=2013&author=Naniwa%2CT&author=Ito%2CR&author=Watanabe%2CM&author=Hayami%2CY&author=Maeda%2CS&author=Sasaki%2CK
- What's https://doi.org/10.1002%2Fart.38398's gross income?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24515813
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20tocilizumab%20in%20conventional%20treatment-refractory%20adult-onset%20Still%E2%80%99s%20disease%3A%20multicenter%20retrospective%20open-label%20study%20of%20thirty-four%20patients%3A%20tocilizumab%20in%20AOSD%20refractory%20to%20standard%20treatment&journal=Arthritis%20Rheumatol&doi=10.1002%2Fart.38398&volume=66&issue=6&pages=1659-1665&publication_year=2014&author=Ortiz-Sanju%C3%A1n%2CF&author=Blanco%2CR&author=Calvo-Rio%2CV&author=Narvaez%2CJ&author=Rubio%20Romero%2CE&author=Oliv%C3%A9%2CA?
- What's the financial outcome of https://doi.org/10.1016%2Fj.autrev.2017.07.017?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28778712
- How profitable is http://scholar.google.com/scholar_lookup?&title=How%20I%20treat%20patients%20with%20adult%20onset%20Still%E2%80%99s%20disease%20in%20clinical%20practice&journal=Autoimmun%20Rev&doi=10.1016%2Fj.autrev.2017.07.017&volume=16&issue=10&pages=1016-1023&publication_year=2017&author=Govoni%2CM&author=Bortoluzzi%2CA&author=Rossi%2CD&author=Modena%2CV?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616309/ income
- How much profit does https://doi.org/10.1093%2Frheumatology%2Fket250 generate?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23864171 have?
- How much does http://scholar.google.com/scholar_lookup?&title=Biologic%20treatments%20for%20adult-onset%20Still%E2%80%99s%20disease&journal=Rheumatology&doi=10.1093%2Frheumatology%2Fket250&volume=53&issue=1&pages=32-38&publication_year=2014&author=Al-Homood%2CIA gross monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616841/?
- What is the monthly revenue of https://doi.org/10.1002%2Facr.21901?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Anakinra%20in%20adult-onset%20Still%E2%80%99s%20disease%3A%20long-term%20treatment%20in%20patients%20resistant%20to%20conventional%20therapy&journal=Arthritis%20Care%20Res&doi=10.1002%2Facr.21901&volume=65&issue=5&pages=822-826&publication_year=2013&author=Giampietro%2CC&author=Ridene%2CM&author=Lequerre%2CT&author=Chalumeau%2CNC&author=Amoura%2CZ&author=Sellam%2CJ produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21682863 gross monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218906 make?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20long-term%20follow-up%20of%20IL-1R%20inhibitor%20anakinra%20in%20adults%20with%20Still%E2%80%99s%20disease%3A%20a%20case-series%20study&journal=Arthritis%20Res%20Ther&doi=10.1186%2Far3366&volume=13&issue=3&publication_year=2011&author=Laskari%2CK&author=Tzioufas%2CAG&author=Moutsopoulos%2CHM?
- Earnings of http://journal.frontiersin.org/article/10.3389/fphar.2017.00369/full
- Get to know https://doi.org/10.1136%2Fard.2007.076034's earnings
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17947302?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Interleukin-1%20receptor%20antagonist%20%28anakinra%29%20treatment%20in%20patients%20with%20systemic-onset%20juvenile%20idiopathic%20arthritis%20or%20adult%20onset%20Still%20disease%3A%20preliminary%20experience%20in%20France&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2007.076034&volume=67&issue=3&pages=302-308&publication_year=2008&author=Lequerr%C3%A9%2CT&author=Quartier%2CP&author=Rosellini%2CD&author=Alaoui%2CF&author=Bandt%2CMD&author=Mejjad%2CO bring in?
- Check the income stats for https://doi.org/10.1080%2F1744666X.2018.1536548
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30324816?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Anakinra%20for%20the%20treatment%20of%20adult-onset%20Still%E2%80%99s%20disease&journal=Expert%20Rev%20Clin%20Immunol&doi=10.1080%2F1744666X.2018.1536548&volume=14&issue=12&pages=979-992&publication_year=2018&author=Casta%C3%B1eda%2CS&author=Atienza-Mateo%2CB&author=Mart%C3%ADn-Varillas%2CJL&author=Serra%20L%C3%B3pez-Matencio%2CJM&author=Gonz%C3%A1lez-Gay%2CMA
- Learn about the earnings of https://doi.org/10.1080%2F1744666X.2017.1375853
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28870100's earnings
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Biologic%20drugs%20in%20adult%20onset%20Still%E2%80%99s%20disease%3A%20a%20systematic%20review%20and%20meta-analysis%20of%20observational%20studies&journal=Expert%20Rev%20Clin%20Immunol&doi=10.1080%2F1744666X.2017.1375853&volume=13&issue=11&pages=1089-1097&publication_year=2017&author=Ruscitti%2CP&author=Ursini%2CF&author=Cipriani%2CP&author=Sarro%2CG&author=Giacomelli%2CR?
- Get to know https://doi.org/10.3109%2F03009742.2014.992949's earnings
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25656459?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20biological%20agents%20in%20adult-onset%20Still%E2%80%99s%20disease&journal=Scand%20J%20Rheumatol&doi=10.3109%2F03009742.2014.992949&volume=44&issue=4&pages=309-314&publication_year=2015&author=Cavalli%2CG&author=Franchini%2CS&author=Aiello%2CP&author=Guglielmi%2CB&author=Berti%2CA&author=Campochiaro%2CC?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19032833?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Clinical%2C%20biological%20and%20sonographic%20response%20to%20IL-1%20blockade%20in%20adult%20onset%20Still%E2%80%99s%20disease&journal=Clin%20Exp%20Rheumatol&volume=26&pages=933-937&publication_year=2008&author=Priori%2CR&author=Ceccarelli%2CF&author=Barone%2CF&author=Iagnocco%2CA&author=Valesini%2CG
- What's the income generated by https://doi.org/10.1097%2FMD.0000000000000021 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Adult-onset%20still%20disease%3A%20manifestations%2C%20treatment%2C%20outcome%2C%20and%20prognostic%20factors%20in%2057%20patients&journal=Medicine%20%28Baltimore%29&doi=10.1097%2FMD.0000000000000021&volume=93&issue=2&pages=91-99&publication_year=2014&author=Gerfaud-Valentin%2CM&author=Maucort-Boulch%2CD&author=Hot%2CA&author=Iwaz%2CJ&author=Ninet%2CJ&author=Durieu%2CI make?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21274538 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Therapeutic%20responses%20and%20prognosis%20in%20adult-onset%20Still%E2%80%99s%20disease&journal=Rheumatol%20Int&doi=10.1007%2Fs00296-011-1801-6&volume=32&issue=5&pages=1291-1298&publication_year=2012&author=Kim%2CH-A&author=Sung%2CJ-M&author=Suh%2CC-H rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16365690 net monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=A%20multicenter%20study%20of%20patients%20with%20adult-onset%20Still%E2%80%99s%20disease%20compared%20with%20systemic%20juvenile%20idiopathic%20arthritis&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-005-0138-5&volume=25&issue=5&pages=639-644&publication_year=2006&author=Pay%2CS&author=T%C3%BCrk%C3%A7apar%2CN&author=Kalyoncu%2CM&author=Sim%C5%9Fek%2CI&author=Beyan%2CE&author=Ertenli%2CI
- How much money does https://doi.org/10.1002%2Fart.27532 generate?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20506370
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20traditional%20and%20biologic%20agents%20in%20different%20clinical%20phenotypes%20of%20adult-onset%20Still%E2%80%99s%20disease&journal=Arthritis%20Rheum&doi=10.1002%2Fart.27532&volume=62&issue=8&pages=2530-2535&publication_year=2010&author=Franchini%2CS&author=Dagna%2CL&author=Salvo%2CF&author=Aiello%2CP&author=Baldissera%2CE&author=Sabbadini%2CMG
- What's the income generated by https://doi.org/10.1136%2Fard.2004.024026 each month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15184196's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Tumour%20necrosis%20factor%20alpha%20blocking%20agents%20in%20refractory%20adult%20Still%E2%80%99s%20disease%3A%20an%20observational%20study%20of%2020%20cases&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2004.024026&volume=64&issue=2&pages=262-266&publication_year=2005&author=Fautrel%2CB&author=Sibilia%2CJ&author=Mariette%2CX&author=Combe%2CB net monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20tocilizumab%20with%20inhibition%20of%20interleukin-6%20in%20adult-onset%20Still%E2%80%99s%20disease%3A%20a%20meta-analysis&journal=Mod%20Rheumatol&volume=18&pages=1-25&publication_year=2017&author=Ma%2CY&author=Wu%2CM&author=Zhang%2CX&author=Xia%2CQ&author=Yang%2CJ&author=Xu%2CS
- Income figures for https://doi.org/10.1136%2Fannrheumdis-2018-213920
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30279267 make?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Tocilizumab%20in%20patients%20with%20adult-onset%20Still%E2%80%99s%20disease%20refractory%20to%20glucocorticoid%20treatment%3A%20a%20randomised%2C%20double-blind%2C%20placebo-controlled%20phase%20III%20trial&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2018-213920&volume=77&issue=12&pages=1720-1729&publication_year=2018&author=Kaneko%2CY&author=Kameda%2CH&author=Ikeda%2CK&author=Ishii%2CT&author=Murakami%2CK&author=Takamatsu%2CH?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25758134?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340831 income
- Earnings of http://scholar.google.com/scholar_lookup?&title=Tolerance%20and%20efficacy%20of%20off-label%20anti-interleukin-1%20treatments%20in%20France%3A%20a%20nationwide%20survey&journal=Orphanet%20J%20Rare%20Dis&doi=10.1186%2Fs13023-015-0228-7&volume=10&issue=1&publication_year=2015&author=Rossi-Semerano%2CL&author=Fautrel%2CB&author=Wendling%2CD&author=Hachulla%2CE&author=Galeotti%2CC&author=Semerano%2CL
- How much revenue does https://doi.org/10.1016%2Fj.jbspin.2013.04.011 generate?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23751410 making per month?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Reactive%20macrophage%20activation%20syndrome%20possibly%20triggered%20by%20canakinumab%20in%20a%20patient%20with%20adult-onset%20Still%E2%80%99s%20disease&journal=Joint%20Bone%20Spine&doi=10.1016%2Fj.jbspin.2013.04.011&volume=80&issue=6&pages=653-655&publication_year=2013&author=Banse%2CC&author=Vittecoq%2CO&author=Benhamou%2CY&author=Gauthier-Prieur%2CM&author=Lequerr%C3%A9%2CT&author=L%C3%A9vesque%2CH?
- How much profit does https://doi.org/10.1097%2FRHU.0000000000000082 make?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24561423
- How much does http://scholar.google.com/scholar_lookup?&title=Successful%20treatment%20of%20refractory%20adult-onset%20still%20disease%20with%20canakinumab%3A%20a%20case%20report&journal=JCR%20J%20Clin%20Rheumatol&doi=10.1097%2FRHU.0000000000000082&volume=20&issue=2&publication_year=2014&author=Barsotti%2CS&author=Neri%2CR&author=Iacopetti%2CV&author=d%E2%80%99Ascanio%2CA&author=Talarico%2CR&author=Tripoli%2CA gross monthly?
- See how much https://doi.org/10.1136%2Fard.2005.047621 makes per month
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16837497 generate?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798247?
- How much does http://scholar.google.com/scholar_lookup?&title=Successful%20treatment%20of%20refractory%20adult%20onset%20Still%E2%80%99s%20disease%20with%20rituximab&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2005.047621&volume=65&issue=8&pages=1117-1118&publication_year=2006&author=Ahmadi-Simab%2CK&author=Lamprecht%2CP&author=Jankowiak%2CC&author=Gross%2CWL pull in monthly?
- What's the income generated by https://doi.org/10.1097%2FRHU.0b013e31822c53ad each month?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21869709?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Refractory%20adult-onset%20Still%20disease%20successfully%20treated%20with%20abatacept&journal=J%20Clin%20Rheumatol&doi=10.1097%2FRHU.0b013e31822c53ad&volume=17&issue=6&pages=315-317&publication_year=2011&author=Ostrowski%2CRA&author=Tehrani%2CR&author=Kadanoff%2CR?
- How much revenue does https://doi.org/10.4081%2Freumatismo.2016.888 produce monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27981819 have monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Successful%20treatment%20of%20refractory%20adult%20onset%20Still%E2%80%99s%20disease%20with%20rituximab&journal=Reumatismo&doi=10.4081%2Freumatismo.2016.888&volume=68&issue=3&publication_year=2016&author=Belfeki%2CN&author=Smiti%20Khanfir%2CM&author=Said%2CF&author=Hamzaoui%2CA&author=Ben%20Salem%2CT&author=Ben%20Ghorbel%2CI
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20483052 income
- Get to know http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20abatacept%20in%20a%20refractory%20case%20of%20adult-onset%20Still%E2%80%99s%20disease&journal=Clin%20Exp%20Rheumatol&volume=28&issue=2&pages=265-267&publication_year=2010&author=Quartuccio%2CL&author=Maset%2CM&author=Vita%2CS's earnings
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23622421?
- How much does http://scholar.google.com/scholar_lookup?&title=Rituximab%20treatment%20for%20pulmonary%20arterial%20hypertension%20in%20adult-onset%20Still%E2%80%99s%20disease&journal=Clin%20Exp%20Rheumatol&volume=31&issue=4&pages=657-658&publication_year=2013&author=Padilla-Ibarra%2CJ&author=Sanchez-Ortiz%2CA&author=Sandoval-Castro%2CC&author=Ramos-Remus%2CC generate monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19917180 make?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Successful%20treatment%20of%20refractory%20adult-onset%20Still%E2%80%99s%20disease%20with%20anti-CD20%20monoclonal%20antibody&journal=Clin%20Exp%20Rheumatol&volume=27&issue=5&pages=888-889&publication_year=2009&author=Bartoloni%2CE&author=Alunno%2CA&author=Luccioli%2CF&author=Santoboni%2CG&author=Gerli%2CR each month?
- How much does https://doi.org/10.1093%2Frheumatology%2Fkeq284 pull in monthly?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Potential%20role%20of%20Th17%20cells%20in%20the%20pathogenesis%20of%20adult-onset%20Still%E2%80%99s%20disease&journal=Rheumatol%20Oxf%20Engl&doi=10.1093%2Frheumatology%2Fkeq284&volume=49&issue=12&pages=2305-12&publication_year=2010&author=Chen%2CD-Y&author=Chen%2CY-M&author=Lan%2CJ-L&author=Lin%2CC-C&author=Chen%2CH-H&author=Hsieh%2CC-W?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14677188 is on a monthly basis
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Serum%20cytokine%20profiles%20in%20patients%20with%20adult%20onset%20Still%E2%80%99s%20disease&journal=J%20Rheumatol&volume=30&issue=11&pages=2422-2427&publication_year=2003&author=Choi%2CJ-H&author=Suh%2CC-H&author=Lee%2CY-M&author=Suh%2CY-J&author=Lee%2CS-K&author=Kim%2CS-S have monthly?
- Explore the financials of https://doi.org/10.1080%2F14397595.2018.1460230
- Revenue of http://scholar.google.com/scholar_lookup?&title=Evidence-based%20clinical%20practice%20guideline%20for%20adult%20Still%E2%80%99s%20disease&journal=Mod%20Rheumatol&doi=10.1080%2F14397595.2018.1460230&volume=13&pages=1-53&publication_year=2018&author=Mimura%2CT&author=Kondo%2CY&author=Ohta%2CA&author=Iwamoto%2CM&author=Ota%2CA&author=Okamoto%2CN
- What's https://citation-needed.springer.com/v2/references/10.1186/s13075-019-1838-6?format=refman&flavour=references's gross income?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Fran%C3%A7ois%20Vercruysse's financial summary
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Fran%C3%A7ois%20Vercruysse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thomas%20Barnetche making per month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thomas%20Barnetche%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Estibaliz%20Lazaro generate?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Estibaliz%20Lazaro%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Emilie%20Shipley make?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Emilie%20Shipley%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Fran%C3%A7ois%20Lifermann generate monthly?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Fran%C3%A7ois%20Lifermann%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alexandre%20Balageas earn?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alexandre%20Balageas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xavier%20Delbrel's revenue stream
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xavier%20Delbrel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bruno%20Fautrel?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bruno%20Fautrel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christophe%20Richez make?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christophe%20Richez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thierry%20Schaeverbeke net monthly?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thierry%20Schaeverbeke%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marie-Elise%20Truchetet have?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marie-Elise%20Truchetet%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does http://creativecommons.org/licenses/by/4.0/ generate?
- What's the monthly money flow for http://creativecommons.org/publicdomain/zero/1.0/?
- How much money does https://s100.copyright.com/AppDispatchServlet?title=Adult-onset%20Still%E2%80%99s%20disease%20biological%20treatment%20strategy%20may%20depend%20on%20the%20phenotypic%20dichotomy&author=Fran%C3%A7ois%20Vercruysse%20et%20al&contentID=10.1186%2Fs13075-019-1838-6©right=The%20Author%28s%29.&publication=1478-6362&publicationDate=2019-02-12&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 generate?
- Income figures for https://crossmark.crossref.org/dialog/?doi=10.1186/s13075-019-1838-6
- Find out how much https://citation-needed.springer.com/v2/references/10.1186/s13075-019-1838-6?format=refman&flavour=citation earns monthly
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's revenue stream
- Get to know what's the income of https://www.springernature.com/gp/products
- How much money does https://www.springernature.com/gp/librarians make?
- How much does https://www.springernature.com/gp/societies earn?
- What are the earnings of https://www.springernature.com/gp/partners?
- How much does https://www.springer.com/ generate monthly?
- What's the monthly money flow for https://www.nature.com/?
- See how much https://www.biomedcentral.com/ makes per month
- What's the total monthly financial gain of https://www.palgrave.com/?
- Financial intake of https://www.apress.com/
- How much does https://www.springernature.com/gp/legal/ccpa rake in every month?
- Revenue of https://www.springernature.com/gp/info/accessibility
- How profitable is https://support.springernature.com/en/support/home?
- What is the earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- See how much https://www.springernature.com/ makes per month
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref